celecoxib,nivolumab,ipilimumab
bms
 niche study as well as update 2022 a few weeks ago, patients got couple of doses of immunotherapy (1ctla4 &amp;2pd1 ) before they went for a colectomy. initial primary endpoint was safety/feasibility, which was met. 
Oncologist | Researcher | ColorectalCancer #CRCSM???????@MayoClinic @PittTweet Alum; ??#ctDNA #LiquidBiopsies??#PrecisionOncology ViewsMy Own. COI @ASCO #ASCO22